These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11328532)

  • 1. Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma.
    Edakuni G; Sasatomi E; Satoh T; Tokunaga O; Miyazaki K
    Pathol Int; 2001 Mar; 51(3):172-8. PubMed ID: 11328532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
    Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of hepatocyte growth factor/c-Met system in nasopharyngeal carcinoma and its biological significance].
    Li Z; Lin SX; Liang HZ; He JH
    Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):75-9. PubMed ID: 15842800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
    Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
    Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatocyte growth factor regulatory factors in human breast cancer.
    Parr C; Watkins G; Mansel RE; Jiang WG
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):202-11. PubMed ID: 14734471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
    Shi BB; Zhang XH; Wang HJ; Li HZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):356-8. PubMed ID: 15312347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.
    Sun YL; Liu WD; Ma GY; Gao DW; Jiang YZ; Liu Q; Du JJ
    Int J Med Sci; 2013; 10(5):548-59. PubMed ID: 23532910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
    Nakashiro K; Hayashi Y; Oyasu R
    Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
    Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT
    Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.
    Camp RL; Rimm EB; Rimm DL
    Cancer; 1999 Dec; 86(11):2259-65. PubMed ID: 10590366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of hepatocyte growth factor and its receptor c-Met correlates with high MIB-1 proliferative index in malignant fibrous histiocytoma.
    Yamamoto T; Marui T; Akisue T; Nakatani T; Fujita I; Matsumoto K; Hitora T; Kawamoto T; Nagira K; Kurosaka M
    Pathol Res Pract; 2004; 200(5):397-402. PubMed ID: 15239348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
    Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
    Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
    Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
    Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
    Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
    J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients.
    Masuya D; Huang C; Liu D; Nakashima T; Kameyama K; Haba R; Ueno M; Yokomise H
    Br J Cancer; 2004 Apr; 90(8):1555-62. PubMed ID: 15083185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease.
    Teofili L; Di Febo AL; Pierconti F; Maggiano N; Bendandi M; Rutella S; Cingolani A; Di Renzo N; Musto P; Pileri S; Leone G; Larocca LM
    Blood; 2001 Feb; 97(4):1063-9. PubMed ID: 11159538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In bone metastasis miR-34a-5p absence inversely correlates with Met expression, while Met oncogene is unaffected by miR-34a-5p in non-metastatic and metastatic breast carcinomas.
    Maroni P; Puglisi R; Mattia G; Carè A; Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2017 May; 38(5):492-503. PubMed ID: 28334277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hepatocyte growth factor (HGF)/scatter factor and its receptor c-MET correlates with poor prognosis in synovial sarcoma.
    Oda Y; Sakamoto A; Saito T; Kinukawa N; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2000 Feb; 31(2):185-92. PubMed ID: 10685632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
    Takeuchi H; Kim J; Fujimoto A; Umetani N; Mori T; Bilchik A; Turner R; Tran A; Kuo C; Hoon DS
    Clin Cancer Res; 2005 Nov; 11(21):7621-8. PubMed ID: 16278380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.